≤134 kDa can passively diffuse into mammalian cell nuclei-thereby contradicting the often-cited 40 kDa diffusion limit. Moreover, their inherent nuclear presence and nuclear accumulation subsequent to proteasome inhibition or abrogated peroxisomal transport suggests that nuclear localization is a characteristic in the lifecycle of peroxisomal proteins. Based on this molecular trafficking analysis, we suggest that pharmaceuticals like propiverine or an NSRI may interfere with peroxisomal protein targeting and import, consequently resulting in massive nuclear protein accumulation in vivo.
Introduction
Massive intranuclear and cytoplasmic protein accumulations of the peroxisomal enzyme d-amino acid oxidase (DAAO) were found in rat proximal tubule epithelial cells after in vivo exposure to pharmaceuticals, e.g., propiverine and a norepinephrine/serotonin reuptake inhibitor (NSRI) (Dietrich et al. 2008; Radi et al. 2013 ). This druginduced accumulation was considered species-and organ 1 3 specific (Dietrich et al. 2008) . However, as the flavoenzyme DAAO (39 kDa) is mainly expressed in kidney, liver, and brain (Baudhuin et al. 1965; Verrall et al. 2007 ) and the fact that various forms of human disorders are attributed to mislocalization and aggregation of proteins (Hung and Link 2011) , we considered it critical to better understand cellular handling of rat and human DAAO. Indeed, since DAAO produces hydrogen peroxide when degrading d-amino acids, mislocalization in the nucleus could provide for a serious threat to the cell integrity, therefore emphasizing that proper subcellular trafficking is essential for cell function and protein homeostasis. Although DAAO has gained increased attention with regard to its role in etiology and pathophysiology of schizophrenia and ALS in humans (Mitchell et al. 2010; Verrall et al. 2010) , little is known about its physiological roles and subcellular trafficking, especially in the context of the unexpected nuclear localization after drug exposure. Since the nucleus represents a major quality control compartment in which misfolded proteins are degraded, impaired degradation can result in protein accumulation (Latonen 2011) . As we have recently demonstrated that propiverine does not affect proteasomal activity in vitro (Luks et al. 2017) , the observed nuclear and cytosolic DAAO accumulation in rat kidneys is unlikely due to an impaired proteasomal degradation. Thus, we hypothesized that altered intracellular trafficking could induce a shift from peroxisomal to nuclear transport of DAAO via two possible mechanisms:
(a) Interference with peroxisomal trafficking: DAAO harbors the peroxisomal targeting signal type 1 (PTS1) defined by the C-terminal conserved tripeptide Ser-HisLeu (SHL) (Gould et al. 1988) . After cytosolic synthesis, PTS1-proteins are transiently present in the cytosol and subsequently transported into peroxisomes in a PEX5-dependent fashion (Smith and Aitchison 2013) .
Since nuclear DAAO accumulation in vivo is accompanied by a complete loss of peroxisomal DAAO (Luks et al. 2017) , interference with the peroxisomal trafficking machinery (e.g., PEX5) may lead to a shift from peroxisomal to nuclear import. (b) Activation of a putative nuclear import signal: Despite the fact that DAAO has no canonical nuclear localization signal (NLS), we identified a putative nuclear translocation signal (NTS). This import signal can facilitate nuclear import via importin 7 after phosphorylation of an S/T-P-S/T sequence (Chuderland et al. 2008) .
While several drugs have been demonstrated to induce nuclear and cytosolic accumulations of DAAO in preclinical trials in rats, albeit with limited associated adverse pathology, the existence and relevance of such protein accumulations in humans remain obscure. For a better human risk assessment, we aimed to identify the molecular mechanism by which propiverine evokes adverse effects in vivo and used an in vitro approach comparing rat and human DAAO in cells of both species. We manipulated single trafficking pathways with which propiverine might interfere resulting in nuclear accumulation in vitro. Using site-directed mutagenesis of EYFP-tagged rat and human DAAO fusion proteins in combination with three different mammalian cells (human kidney HEK293, rat kidney proximal tubule WKPT, and human glioblastoma U87 cells), we altered intracellular protein transport and induced nuclear mislocalization of DAAO. We were able to demonstrate the omnipresence of DAAO in the nucleus of DAAO-overexpressing cells and showed that passive diffusion-but not active import-is causal for nuclear DAAO localization. In conjunction with the latter, our data imply that passive diffusion of molecules ≥40 kDa is an inherent characteristic of the nuclear pore complex (NPC) in the mammalian cells tested.
Materials and methods

Expression constructs
Mammalian pEYFP-C3, pEYFP-rDAAO-C3, and pEYFPhDAAO-C3 expression vectors (Sacchi et al. 2008 Frattini et al. 2011) were used for overexpression of EYFP-DAAO in HEK293, WKPT, and U87 cells. pEX-K4-HindIII-hCAT-EcoRI and pEX-K4-HindIII-rCAT-EcoRI were purchased from Eurofins Genomics and were used for subcloning of hCAT and rCAT cDNA into the pEYFP-C3 backbone. The bacterial expression vectors pET28-rDAAO and pET11b-hDAAO (Frattini et al. 2011; Romano et al. 2009 ) were used for expression of His-DAAO in BL21 (DE3) E. coli cells.
Bacterial strains
TOP10 chemically competent E. coli cells were purchased from Invitrogen and used as host for vector propagation and site-directed mutagenesis. BL21 (DE3) and chemically competent DH5α E. coli cells were used for expression of recombinant His-tagged proteins and for molecular cloning of pEYFP-r/hCAT-C3, respectively.
Site-directed mutagenesis
FASTA sequences of rDAAO (O35078), hDAAO (P14920), rCAT (P04762), and hCAT (P04040) were derived from UniProtKB and used for signal sequence analysis. Sitedirected mutagenesis (Table 1 ) was performed as previously described (Edelheit et al. 2009 ). Briefly, the parental plasmid was amplified in two separate PCR reactions containing either forward or reverse primer carrying the desired mutation. Primers were purchased from Eurofins Genomics. For single-primer PCR, 500 ng vector DNA, 40 pmol forward or reverse primer, 0.2 mM dNTPs, 1× complete pwo buffer, and 1.25 U pwo polymerase (Peqlab) were used in a 25 µL PCR reaction in a C100™ Thermal Cycler (BioRAD). Subsequently, the single-primer PCR reactions were combined, denatured and gradually reannealed as follows: 95 °C for 5 min, 90 °C for 1 min, 80 °C for 1 min, 70 °C for 0.5 min, 60 °C for 0.5 min, 50 °C for 0.5 min, 40 °C for 0.5 min, and 37 °C for infinite. Afterwards, methylated parental DNA was digested using 30 U DpnI (NEB) at 37 °C O/N. After heat-inactivation of DpnI at 80 °C for 20 min, 50 µL chemically competent E. coli Top10 were transformed via heat shock (42 °C for 90 s) with 10 µL of the DpnI-digested PCR mix. After 60 min of phenotypic expression, 300 and 700 µL of bacterial suspension were spread on LB-plates (30 µg/mL kanamycin) and grown O/N at 37 °C. 5-8 colonies were grown in 5 mL LB-kan O/N at 37 °C and 220 rpm. Plasmid preparation was performed according to manufacturers' instructions (GeneJet Plasmid Miniprep, Thermo Scientific). Sequencing was performed by Eurofins Genomics and analyzed using BLASTn-Nucleotide BLAST (NCBI).
Cell culture
HEK293 (human embryonic kidney) cells were purchased from the Leibniz Institute DSMZ-German Collection of Microorganisms and Cell Cultures. HEK293 cells were cultured in Dulbecco's modified Eagle's medium (DMEM) containing low glucose (1 g/L) supplemented with 10% (v/v) fetal bovine serum (FBS) gold, 100 U/mL penicillin, and 0.1 mg/mL streptomycin. WKPT (WKY rat, kidney proximal tubule) cells were kindly provided by Prof. Dr. Frank Thevenod (University of Witten/Herdecke, Germany) and were cultured in DMEM Nutmix F12 (Ham) containing 10% (v/v) FBS, 100 U/mL penicillin and 0.1 mg/mL streptomycin, 1.2 mg/mL NaHCO 3 , 5 µg/ mL insulin, 4 µg/mL dexamethasone, 0.01 µg/mL EGF, and 5 µg/mL apo-transferrin. Cell lines were routinely tested for mycoplasma contamination (GATC). Human U87 glioblastoma cells (ATCC) were cultured in DMEM supplemented with 10% fetal bovine serum, 1 mM sodium pyruvate, 2 mM l-glutamine, penicillin/streptomycin, and amphotericin B (Euroclone) at 37 °C in 5% CO 2 .
Transfection
For transient transfection, HEK293 and WKPT cells were seeded at cell densities of 4E4 cells/cm 2 and U87 at 1E4 cells/cm 2 into eight-well chamber slides (Sarstedt, #94.6190.802). Chamber slides for HEK293 seeding were coated with poly-d-lysine. 24 h after seeding, cells were transfected with 2 µg vector DNA using a 3:1 ratio of FuGENE transfection reagent (Promega) to DNA for HEK293 and a 4:1 ratio for WKPT and U87 cells. Finally, 25 µL of transfection:DNA mix was added to 500 µL medium per well for HEK293 and WKPT. For U87 cells, 20 µL of transfection:DNA mix was added to 350 µL medium per well.
Immunocytochemistry 72 h after transfection, cells were washed once with warm PBS and fixed with warm 2% p-formaldehyde (PFA)/0.1% Triton X-100 for 10 min. For degradation inhibition experiments, cells were fixed 24 h after treatment with degradation inhibitors. After fixation, cells were washed twice with PBS and blocked with 1% (w/v) BSA in PBS for 30 min at RT. Primary antibody against PMP70 (1:400, rabbit polyclonal, Sigma-Aldrich, #P0497), mono-and Elgersma et al. (1996) CAT-ΔPTS ΔKANL Purdue and Lazarow (1996) , Trelease et al. (1996) Control for active nuclear import NLS PKKKRKVE CCAAAAAAGAAACGTAAGGTCGAA Kalderon et al. (1984a, b) Phosphomimetic NTS EPE EPE GAGCCCGAG Chuderland et al. (2008) Non-phosphorylatable NTS APA APA GCCCCCGCC Chuderland et al. (2008) Control for active nuclear export NES LAVKFAGLDL CTGGCCGTGAAATTCGCCGGCCTGGACCTG Bogerd et al. (1996) , Fried and Kutay (2003) polyubiquitinylated conjugates (FK2, 1:100, mouse monoclonal, Enzo, #BML-PW8810-0100), SUMO1 (1:100, mouse monoclonal, Santa Cruz, #sc-5308), and NOH61 (1:10, mouse monoclonal, Progen, #651126) were diluted in blocking buffer and incubated O/N at 4 °C. Cells were then washed three times with PBS for 5 min and incubated with diluted Alexa Fluor ® 647 secondary antibody (1:1000, goat anti-rabbit IgG/rabbit anti-mouse IgG, Life Technologies, # A-21244/A-21239) for 1 h at RT light-protected. After washing, HEK293 and WKPT cells were stained with Hoechst33342 (Calbiochem ® ) and U87 cells with DRAQ5TM (Thermo Scientific, #62251) for 10 min at RT in the dark. Cells were washed three times with PBS and stored in PBS at 4 °C until imaging.
Confocal microscopy
Cells were fixed and analyzed 48-96 h after transfection. Best results were obtained after 72 h and used as representative data if not stated otherwise. HEK293 and WKPT cells were imaged using a point laser scanning confocal microscope LSM 880 (Zeiss) equipped with a 63.0×/1.40 oil immersion objective and ZEN software (Zeiss) (University of Konstanz). Analyses of U87 cells were carried out using an inverted laser scanning confocal microscope (TCS SP5, Leica Microsystems), equipped with a 63.0 × 1.25 NA plan apochromate oil immersion objective (University of Insubria, Varese). Multiple fluorophores were imaged via sequential scanning. All pictures are representative for at least three independent experiments (n = 3). If not stated otherwise, the same laser intensities were applied for control and treated cells. Note that for Figs. 3 and S3d, investigators were blinded to allocation during imaging.
Recombinant proteins
pET11b-His-hDAAO and pET28-His-rDAAO expression vectors were used to express His-DAAO in BL21(DE3) Star E.coli cells and purified as previously reported (Frattini et al. 2011; Molla et al. 2006) . Using site-directed mutagenesis, His-h/rDAAO-ΔPTS mutants were generated from pET11b-His-hDAAO and pET28-His-rDAAO expression vectors, respectively (see above).
Oxygen consumption assay
Activity of DAAO was measured by oxygen consumption using a Clark electrode at 25 °C in 75 mM sodium pyrophosophate buffer (pH 8.5), 28 mM (hDAAO) or 1 M d-alanine (rDAAO), and 200 µM FAD (hDAAO) or 5 µM FAD (rDAAO). Higher FAD concentrations for hDAAO are necessary due to a ~10× lower binding affinity for FAD.
Higher d-alanine concentrations were used for rDAAO due to lower substrate specificity (Frattini et al. 2011 ).
Far-and near-UV circular dichroism (CD) spectral analysis
Spectroscopic experiments were performed as reported previously (Caldinelli et al. 2009 ) in 20 mM Tris-HCl (pH 8.0), 100 mM NaCl, 10% glycerol, and 5 mM 2-mercaptoethanol. Note that for experiments with hDAAO, the buffer contained additional 40 µM FAD to favor holoenzyme production resulting in the typical FAD spectrum as observed in the near-UV spectrum of hDAAO (Fig. 1d , bottom, light gray). CD spectra were recorded on a Jasco J-810 spectropolarimeter at 15 °C.
Knockdown of PEX5
SMARTpool PEX5 siRNA (L-015788-00-0005) and ON-TARGETplus non-targeting pool siRNA (D-001810-10-05) were purchased from Dharmacon. HEK293 cells were transfected according to the manufacturer's instructions with a final concentration of 10 nM siRNA and 4 µL/ well transfection reagent. For protein analysis of PEX5 knockdown, wild-type or stably transfected HEK293 cells expressing rDAAO or hDAAO were seeded in a six-well plate with a density of 3.3 E4 cells/cm 2 and harvested 48-72 h after siRNA knockdown. For confocal analysis, wild-type HEK293 cells were seeded onto cover slips in a six-well plate, medium was removed 24 h after siRNA transfection, and cells were subsequently transfected with EYFP-DAAO. 48 h after transfection, cells were fixed and stained for confocal microscopy. Note that non-treated and negative siRNA pool-treated cells show comparable PEX5, DAAO, and actin level.
SDS-PAGE and Western blotting
For protein analysis, cells were washed once with cold PBS, scraped off in PBS, and collected in a 1.5 mL reaction tube on ice. Pelleted cells were lyzed in RIPA buffer (50 mM Tris-HCl, 150 mM NaCl, 0.1% SDS, 0.5% sodium deoxycholate, 1% Triton X-100, and Halt™ Protease Inhibitor Cocktail (Thermo Scientific)) for 10 min on ice. After vortexing, lysates were centrifuged at 16000×g for 10 min. The protein concentration in the supernatant was determined using the BCA Protein Assay (#23225, Thermo Scientific). Proteins were denatured by boiling for 5 min at 95 °C in SDS buffer (187.5 mM Tris-HCl pH 8.8, 10% (v/v) glycerol, 2% (w/v) SDS, 20% (v/v) 2-mercaptoethanol, and 1% (w/v) bromophenol blue). 20 µg protein per lane was loaded onto a 12% gel, separated by SDS-PAGE and blotted onto a nitrocellulose membrane. The membrane was blocked with 5% (w/v) milk powder in TTBS (100 mM Tris-HCl, 150 mM NaCl, 0.1% (v/v) Tween 20, pH 7.6) for 40 min. The following antibodies were diluted in 5% milk powder and incubated O/N at 4 °C: anti-PEX5 (1:1000, mouse, Abcam, #125689), anti-DAAO (1:5000, sheep, Antibodies online, #94967), and anti-β-actin (1:2000, mouse, Sigma-Aldrich, #A2228). After removal of unbound primary antibodies, membranes were incubated for 1 h at RT with peroxidase-conjugated secondary antibodies (antimouse IgG-peroxidase, 1:80,000, Sigma-Aldrich, #A9044; anti-sheep IgG-peroxidase, 1:10,000, Sigma-Aldrich, #A3415) and signals were detected by enhanced chemiluminescence (ECL ultra, Lumigen, #TMA-6).
Native PAGE Cells were harvested as described above, resuspended in cold lysis buffer (50 mM Tris-HCl pH 7.5, 150 mM NaCl, 0.5 mM EDTA pH 8, 0.5% NP-40, 1 mM PMSF, and Halt™ protease inhibitor cocktail (Thermo Scientific)) and lyzed on ice by passing repeatedly through a 27G needle. After centrifugation at 20,000×g for 10 min at 4 °C, the supernatant was subjected to BCA Protein Assay (Thermo Scientific, #23225) to determine protein levels. Proteins were denatured by boiling for 5 min at 95 °C in native PAGE sample buffer (62.5 mM Tris-HCl pH 6.8, 25% (v/v) glycerol, and 0.1% (w/v) bromophenol blue). 20 µg total protein was separated by 12% SDS-PAGE and blotted onto a nitrocellulose membrane. EYFP-fusion proteins were detected using anti-GFP antibody (1:1000 in 5% milk, mouse, Roche, #1814460001) and anti-mouse IgG-peroxidase as described above. Note that EYFP-only (30 kDa) and hDAAO (135 kDa) were used on every blot as "protein size marker".
Inhibition of protein degradation and quantitative imaging
For high-content screening, HEK293 cells stably expressing hDAAO or rDAAO (similar expression levels) were seeded into a 96-well plate coated with poly-d-lysine. 24 h after seeding, cells were treated either with DMSO control, 50 µM chloroquine (Sigma-Aldrich, #C6628), or 1 µM epoxomicin (Santa Cruz, #sc-201298) . Note that 0.5 µM epoxomicin was used for confocal microcopy. Cells were fixed 24 h after treatment as described above, stained with Hoechst33342 (Calbiochem), and nuclear-cytoplasmic fluorescence was measured using Cellomics (ArrayScan and CellInsight, Thermo Scientific) as described previously (Henn et al. 2011) . Briefly, the border of the nuclear stain ("circle") was used to create a mask for identification of nuclear localization and an annulus mask ("ring") was used to assess cytosolic localization. The total intensity of EYFP inside both the masks was averaged per well by analyzing 200 cells per well. Relative fluorescence units (RFU) were calculated based on the following equation and normalized to cell count:
Data handling and statistical analyses
If images are labeled with "DAAO", experiments were performed for both rDAAO and hDAAO. However, results can be interpreted equally for both hDAAO and rDAAO constructs. Image analysis was performed using the (Fiji Is just) ImageJ software. The Pearson's correlation coefficient (r) was determined using Fiji Colok 2 analysis of single cells (whole cells were used if not otherwise indicated, e.g., r cyt ) using the following settings: bisection threshold regression and point spread function (PSF) of 12 and 100 Costes randomizations. Intensity line plot profiles were obtained from Fiji Multi Plot analysis. For illustration, pixel intensities were normalized to min and max values (represented as %). The relative nuclear intensity (RNI) was calculated based on mean gray intensities for single cells and calculated as follows: RNI = intensity nucleus /intensity cytosol . On average, five biological replicates (36 cells) for HEK293 and four biological replicates (50 cells) for WKPT and three biological replicates (65 cells) for U87 were used for each mutant. GraphPad Prism 5 was used for statistical analysis and PyMOL for conformational analysis.
Online supplemental material S1 shows that rDAAO-ΔPTS is correctly folded and active, and is localized in the nucleus and cytosol in WKPT cells. PEX5 knockdown leads to a decrease of the Pearson's coefficient of PMP70 and DAAO. S2 shows the cross-talk of PTS-and NLS-targeting signals independent of their localization within the DAAO sequence. S3 shows native PAGE of DAAO and CAT oligomeric constructs and the quantification and confocal analysis of the constructs in WKPT cells.
Results
Impaired peroxisomal trafficking leads to cytosolic and enriched nuclear DAAO
The majority of peroxisomal proteins like DAAO is synthesized in the cytosol and post-translationally transported via their C-terminal PTS1 into peroxisomes. To better understand how DAAO might enter the nucleus-a phenomenon observed after in vivo administration of several mean intensity (circle) mean intensity (ring) + mean intensity (circle) × 100%.
drugs (Dietrich et al. 2008; Radi et al. 2013 )-we manipulated peroxisomal trafficking of DAAO. First, we investigated the subcellular localization of EYFP-tagged human and rat DAAO overexpressed in HEK293, WKPT and U87 cells, usually expressing DAAO protein at levels below detection, using confocal microscopy. As expected, wildtype human (hDAAO, Fig. 1a ) and rat DAAO (rDAAO, Fig. S1a ) showed peroxisomal localization, as indicated by co-localization with the peroxisomal membrane protein 70 (PMP70). Indeed, Pearson's correlation coefficient (r) values obtained for hDAAO (r = 0.81, Fig. 1a ) and rDAAO (r = 0.79, Fig. S1a ) corroborated the latter finding. We visualized the localization of EYFP-DAAO (yellow), PMP70 (red), and Hoechst (blue) using a line plot profile (Fig. 1a) . The pixel intensity of EYFP-DAAO and PMP70 along the arrow-depicted in the merge paneldisplayed distinct overlapping spikes, where the line passes through peroxisomes (Fig. 1a) . Next, we manipulated the peroxisomal import of DAAO by deleting the two C-terminal amino acids of the PTS1 sequence (hereinafter referred to as ΔPTS) by site-directed mutagenesis. The latter resulted in a diffuse nuclear and cytosolic figure) and near-UV (lower figure) circular dichroism (CD) spectra of recombinant His-hDAAO and His-hDAAO-ΔPTS. d Enzymatic activity of His-hDAAO and His-hDAAO-ΔPTS1 determined using oxygen consumption. Mean ± SEM, n = 3. Unpaired t test, ns = not significant. e Confocal microscopy of HEK293, WKPT and U87 cells transiently transfected with EYFP-h/rDAAO-ΔPTS. Quantification of relative nuclear intensity of EYFP signal (intensity nucleus /intensity cell ). Mean ± SEM, n = 5 for HEK293, n = 4 for WKPT and n = 3 for U87 cells. Unpaired t test, *p < 0.05, ns = not significant. f Representative Western blot of PEX5 knockdown using siRNA in HEK293 cells stably expressing EYFP-hDAAO. Actin and DAAO were used as controls. Quantification of knockdown efficiency in wild-type, human and rat DAAO expressing cells presented as mean ± SEM, n = 3. Unpaired t test, *p < 0.05. g Confocal analysis and line plot profile of HEK293 cells expressing EYFP-DAAO 24 h after knockdown of PEX5. h/rDAAO = EYFP-tagged human/rat DAAO. PMP70 = peroxisomal membrane protein 70. PTS = peroxisomal targeting signal. PEX5 = peroxisomal biogenesis factor 5. Scale bar 10 µm distribution of hDAAO (Fig. 1b) and rDAAO (Fig. S1b) . Interestingly, we observed a higher EYFP signal in the nucleus, thus suggesting directed nuclear transport of DAAO. The Pearson's r values for hDAAO-and rDAAO-ΔPTS (r = −0.12 and r = −0.05) indicated the lack of DAAO-ΔPTS and PMP70 co-localization (Figs. 1b, S1b) . Indeed, the line plot profile confirmed that DAAO-ΔPTS is predominantly localized in the nucleus, indicated by a higher EYFP pixel intensity inside the nucleus that then gradually decreased towards the cytosol (Figs. 1b, S1b) . Moreover, perinuclear protein accumulations were formed that most likely represent aggresomes (Garcia-Mata et al. 1999) (Figs. 1b, S1b ). Nuclear import secondary to misfolding or loss-of-function (Park et al. 2013 ) was considered unlikely since DAAO-ΔPTS mutants were not altered in their secondary and tertiary protein structures as well as in their enzymatic activity (Figs. 1c, d, S1c, d ).
These results demonstrate that impairment of correct peroxisomal targeting and import provoked nuclear DAAO mislocalization.
To better characterize the subcellular localization of ΔPTS variants in HEK293, WKPT, and U87 cells, we quantified the nuclear localization by calculating the relative nuclear intensity (RNI = intensity nucleus /intensity cell ) (Fig. 1e) . Both confocal analysis and signal quantification revealed an enrichment of EYFP signal in the nucleus (RNI > 1). Of importance, appears the finding that the nuclear signal was invariably higher for rDAAO-ΔPTS than for hDAAO-ΔPTS, both in human-derived HEK293 and U87, and rat-derived WKPT cells, suggesting a cell line independent albeit protein-species dependent effect (Fig. 1e) . To strengthen the hypothesis that disturbed peroxisomal trafficking is causal for nuclear localization of DAAO, we partially silenced PEX5, the cytosolic receptor for PTS1 proteins. siRNA silencing resulted in a significant downregulation of PEX5 protein (53%), while affecting neither DAAO nor actin protein expression (Fig. 1f) , and led to a diffuse nuclear and cytosolic localization of DAAO (Fig. 1g, +siRNA) . The line plot profile confirmed a higher nuclear EYFP signal in PEX5-silenced cells (Fig. 1g, lower panel) . The remaining PEX5 still accounted for some peroxisomal transport of DAAO, as quantified by co-localization analysis with PMP70 (r −siRNA = 0.6; r +siRNA = 0.29) (Fig. S1e) . Taken together, we were able to induce nuclear DAAO localization-to date only observed in vivo (Dietrich et al. 2008; Radi et al. 2013 )-by preventing peroxisomal targeting and import of the overexpressed protein via deletion of the PTS1 signal or suppression of the PEX5 receptor, respectively. Thus, the enriched nuclear DAAO and the absence of an NLS in the DAAO sequences beg the question, whether an NTS could be responsible for active nuclear import.
Interplay of multiple targeting signals and their influence on subcellular trafficking
Although having 80% sequence homology, rDAAO and hDAAO may differ in their repertoire and functionality of signal sequences. Indeed, we discovered different putative and accessible NTS (TPx) variants within the DAAO sequences: T 117 -P 118 -S 119 for rDAAO and T 118 -P 119 -R 120 for hDAAO (Fig. 2a) . Since phosphorylation of an arginine (e.g., R 120 ) is less frequent than phosphorylation of serine or threonine (Ciesla et al. 2011) , nuclear transport of hDAAO may be less efficient, thus possibly explaining the observed lower nuclear accumulation for hDAAO than for rDAAO (Fig. 1e) . We replaced serine (S 119 ) in rDAAO, arginine (R 120 ) in hDAAO, and threonine (T 117/118 ) with glutamate (E) via site-directed mutagenesis to mimic phosphorylation and thus activation of the NTS (Fig. 2a, b) (Chuderland et al. 2008) . The phosphomimetic EPE-DAAO mutant was exclusively found in peroxisomes (Fig. 2b) , with a similar Pearson r value (r = 0.77) and line plot profile as wild-type DAAO (r = 0.81) (Fig. 1a) . To avoid potential multiple targeting (Ast et al. 2013) , we deleted the PTS1 of activated (EPE-DAAO) and inactivated (APA-DAAO) NTS constructs (Fig. 2a) . Inactivation of the NTS was achieved by replacing glutamate with non-phosphorylatable alanine (A) (Chuderland et al. 2008) . The activity of the NTS had no effect on the subcellular distribution of DAAO (Fig. 2b-d) , i.e., it was comparable to the DAAO-ΔPTS1 mutant (Fig. 1b) . By adding a classic monopartite NLS (PKK-KRKVE) N-terminally of DAAO either possessing an active (Fig. 2e ) or deleted PTS1 (Fig. 2f) , we showed the competition of NLS and PTS signals and thereby confirmed the influence of multiple targeting signals. Note that the relative position of NLS and PTS had no influence on protein localization (Fig. S2a, b (a, b, c) ), while the PTS1 is only accessible when placed at the very C-terminus (Fig. S2a, b (d) ). In addition, nuclear DAAO localization observed for the ΔPTS mutants (Figs. 1b, S1b ) was significantly less compared to when a classical NLS was added (Figs. 2f, S2d-g ). We thus conclude that the putative NTS in DAAO is not functional and the observed nuclear localization of DAAO most likely does not result from active import via an internal nuclear trafficking signal. Contrary to our initial hypothesis and currently published evidence, we questioned whether nuclear localization of DAAO could have resulted from passive diffusion when import into the peroxisomes is inhibited.
The nuclear barrier is not rigid, allowing peroxisomal proteins to enter the nucleus depending on their molecular weight
Contrary to the fact that past research suggested that only small proteins ≤~40 kDa can passively diffuse through nuclear pore complexes (NPCs) (Paine and Feldherr 1972; Keminer and Peters 1999; Ma et al. 2012; Knockenhauer and Schwartz 2016) , our observations would imply that also much larger proteins passively diffuse into the nucleus. Indeed, the size difference of EYFP-rDAAO (a 67 kDa monomer) and hDAAO (a 135 kDa dimer (Frattini et al. 2011) ) could explain the greater nuclear enrichment of rDAAO-ΔPTS compared to hDAAO-ΔPTS (Fig. 1c) . To corroborate the latter as well as to better understand sizedependent nuclear diffusion, we increased the mass of the DAAO-ΔPTS mutants from 67 to 94 kDa (rDAAO) and from 135 to 189 kDa (hDAAO) by inserting mCherry (mCh, 27 kDa) into the DAAO constructs (Fig. 3a (f, i) , b). Catalase (CAT) served as an additional example for a peroxisomal protein yet with a higher molecular weight (Lazarow and de Duve 1973; Vainshtein et al. 1981) , thus allowing us to rule out protein-specific effects (Fig. 3a  (j-m), b) .
The diffusion capability of the different constructs was calculated via the relative nuclear intensity (RNI = intensity nucleus /intensity cell ) (Fig. 3c) . EYFP-only (Fig. 3c, d (a) ) served as diffusion control and, interestingly, demonstrated an RNI of 1.27, indicating that the 30 kDa EYFP protein is enriched in the nuclear compartment. Indeed, the nucleus features a higher heterogeneity leading to reduced mobility of proteins (Baum et al. 2014) , thus most likely explaining the trapping of EYFP inside the nucleus. As an active import control, we fused the classic, monopartite NLS to DAAO and observed-as expected-an exclusive localization of NLS-DAAO in the nucleus (RNI NLS-hDAAO = 1.79; RNI NLS-rDAAO = 1.67) (Fig. 3c, d (b, c) ). Wild-type r/hDAAO solely localized to peroxisomes; therefore, the RNI is <1 (RNI hDAAO = 0.78; RNI rDAAO = 0.77) (Fig. 3c, d  (d, g) ). Deletion of the PTS1 resulted in nuclear enrichment of both hDAAO-ΔPTS (RNI = 1.2) and the rDAAO-ΔPTS (RNI = 1.34) but strikingly is not significantly different to EYFP-only distribution (Fig. 3c, d (e, h, a) ). Contrary to the postulated threshold of ≤~40 kDa for passive diffusion, the dimeric 134 kDa hDAAO-ΔPTS mutant passively diffused into the nucleus-albeit less efficiently than the 67 kDa rDAAO-ΔPTS mutant (Fig. 3c (h, e) ). Using native PAGE, we confirmed the reported multimeric states of our constructs verifying that hDAAO exists as dimer and rDAAO and ΔPTS mutant; e NLS-DAAO, control for active nuclear and concomitant peroxisomal import; r cyt = r value for cytosolic region only and f NLS-DAAO-ΔPTS, control for active nuclear import. Nuclei are labeled with Hoechst33342 and are indicated by dashed lines. DAAO = EYFP-tagged human/rat DAAO. PMP70 = peroxisomal membrane protein 70. PTS = peroxisomal targeting signal. NTS = nuclear translocation signal. NLS = nuclear localization signal. Scale bar 10 µm as monomer in our cell systems (Fig. S3a) . The second band of rDAAO on the native PAGE might be a post-translational modification which was not observed for hDAAO (Fig. S3a) . The 94 kDa mCh-rDAAO-ΔPTS construct was also found to accumulate in the nucleus (RNI = 1.19), comparable to hDAAO-ΔPTS (Fig. 3c, d (f, h) ). However, increasing the molecular mass to 189 kDa (i.e., with the dimeric mCh-hDAAO-ΔPTS construct) resulted in a significant exclusion from the nucleus (RNI = 0.69; Fig. 3c,  d (i) ). As expected, the catalase constructs (≥349 kDa; Fig. 3a) did not show nuclear accumulation, irrespective of the PTS deletion, whereby the nuclear exclusion was comparable to that observed for mCh-hDAAO-ΔPTS (Fig. 3d (k, m, i) ). However, hCAT-ΔPTS displayed a stronger nuclear exclusion (RNI = 0.65) than rCAT-ΔPTS (RNI = 0.94), although both protein species were reported to occur as ~350 kDa tetramers (Fig. 3a, c, d (k, m) ) (Lazarow and de Duve 1973; Vainshtein et al. 1981) . Native PAGE revealed multiple bands for r/hCAT indicating that the proteins were present in several oligomeric states (Fig.  S3a) , whereby rCAT and rCAT-ΔPTS appeared to be primarily dimers (175 kDa) and trimers (263 kDa), and hCAT and hCAT-ΔPTS also formed tetramers (~349 kDa). The latter finding would explain the stronger nuclear exclusion of hCAT-ΔPTS. Due to the smaller size of dimeric/ trimeric rCAT-ΔPTS proteins, they have a higher mobility and efficiency in passing through NPCs (Baum et al. 2014) ; therefore, diffusion into the nucleus may be facilitated. Consequently, these findings provide evidence for a size-dependent decrease in passive diffusion. Indeed, while RNIs of constructs expected to passively diffuse (filled symbols) correlate nicely to protein mass, the RNIs of constructs showing active import (RNI NLS-DAAO = 1.79) or active export (RNI NES-DAAO = 0.67) do not fit the linear correlation (open symbols) (Fig. 3e) . The fact that we obtained comparable results in WKPT (Fig. S3b, c) and U87 cells (data not shown) and the strong correlation between RNI and protein size (kDa) demonstrates the absence of a threshold for passive protein diffusion into the nucleus and a decrease of diffusion capability with protein mass.
Based on above premises, we hypothesized that newly synthesized, transiently cytosolic DAAO should also diffuse into the nucleus whilst being targeted to peroxisomes. We confirmed the inherent presence of nuclear DAAO (Fig. 4a) and CAT (data not shown), using confocal microscopy (constant laser power) at several timepoints after transfection, a finding also corroborated via Cellomics (Fig. 4b, control) . Note that in confocal microscopy, the presence of nuclear proteins may easily be missed due to a dense, local fluorescence intensity in small compartments like peroxisomes (Fig. 4a, 72 h ). Since only nuclear proteasome substrates accumulate in nuclear aggresomes after proteasome inhibition , we treated transfected HEK293 cells with epoxomicin, a well-established proteasome inhibitor. We observed an accumulation of nuclear but not cytosolic DAAO and CAT, whereas the lysosomal inhibitor chloroquine had no effect ( Fig. 4b ; data not shown for CAT), contrasting earlier reports in U87 cells overexpressing EYFP-hDAAO (Cappelletti et al. 2014) . Moreover, accumulations of EYFP-DAAO in HEK293 cells were found to be ubiquitinated, SUMOylated, and localized in close proximity to the nucleoli (Fig. 4c) . These data suggest that DAAO is neither degraded via lysosomes nor via the cytosolic but rather the nuclear proteasomal degradation pathway. Consequently, nuclear "mislocalization" of peroxisomal proteins may represent a part of normal cell physiology that can be better observed in DAAO-overexpressing cells. However, cells can counteract mislocalized nuclear proteins by actively exporting them from the nucleus via exportins, e.g., CRM1 (Kirli et al. 2015) . Thus, we asked whether or not DAAO can be actively exported from the nucleus and whether this mechanism is impaired when DAAO accumulates in the nucleus. However, despite that we found a putative and surfaceexposed nuclear export signal (NES) in DAAO, treatment Overexposed regions are marked in red. b Fluorescence intensity in EYFP-DAAO-HEK293 cells exposed to 50 µM lysosomal inhibitor chloroquine or 1 µM proteasomal inhibitor epoxomicin for 24 h. Increase in EYFP signal was quantified using Cellomics and normalized to cell count. Mean ± SEM, n = 4 with 6 technical replicates.
One-way ANOVA with Dunnett's post-test, *p < 0.01. c Confocal microscopy of transiently transfected HEK293 cells expressing EYFP-DAAO treated with 50 µM chloroquine or 0.5 µM epoxomicin for 24 h. Nuclei are indicated by dashed lines. Cells are stained for mono-and polyubiquitinylated conjugates (FK2), SUMOylation (SUMO) and nucleoli (NOH61). DAAO = EYFP-tagged human/rat DAAO. RFU = relative fluorescence units. FK2 = mono-and polyubiquitinylated conjugates. SUMO = small ubiquitin-like modifier. NOH61 = nucleolar helicase. Scale bar 10 µm of wild-type DAAO and DAAO-ΔPTS with leptomycin B, a potent CRM1 inhibitor, did not change localization of either DAAO construct (Fig. 5 , black + gray bars). On the contrary, nuclear localization of DAAO-ΔPTS containing a consensus NES sequence (Fig. 5 , white bars) was significantly increased following treatment with leptomycin B. These results strongly suggest that DAAO contains no functional NES sequence that would counteract passive diffusion into the nucleus.
Discussion
Our study addressed the question how peroxisomal proteins, i.e., DAAO, end up accumulating in the nucleus of rat proximal tubule cells after pharmaceutical exposure. Since interference with the cyto-nuclear shuttling did not result in any change in DAAO distribution, we consider this particular mechanism unlikely to be involved in propiverine-induced pathology. However, we provide evidence that peroxisomal proteins, e.g., DAAO and CAT, are not exclusively localized in peroxisomes but are also continuously present in the nucleus as suggested previously (Kirli et al. 2015; Kolodney et al. 2015) . This is further corroborated by our findings that wild-type DAAO and CAT are primarily degraded via the nuclear proteasome. Moreover, we were able to demonstrate that this nuclear presence is mediated via passive diffusion rather than by active import mechanisms. Indeed, contrary to other studies, we provide strong evidence that the often-cited size exclusion limit of ~40 kDa for passive diffusion into the nucleus in mammalian cells is most likely not stringent. Indeed, using bulky EYFP-and mCherry-fusion proteins having a natural tertiary structure, instead of using pearl-like GFP oligomers (Seibel et al. 2007; Wang and Brattain 2007) that might artificially facilitate the passage through nuclear pores, we were able to demonstrate the passive diffusion of larger proteins into the nucleus. We observed a linear correlation between nuclear diffusion and protein mass. Thus, our data corroborate and complement the recently published "soft barrier" model for passive protein diffusion reported for yeast, defining that passive diffusion of large, complex molecules is not "leakage" but rather an inherent characteristic of the NPC (Timney et al. 2016) . Moreover, verifying the activity of isolated DAAO-ΔPTS protein, we assume that EYFP-DAAO-ΔPTS is also active in cells, i.e., inside the nucleus. We suggest that cells can cope with nuclear mislocalization of H 2 O 2 -producing proteins, since a nucleartargeted DAAO mutant (NLS-DAAO) was demonstrated to produce increased nuclear ROS levels yet without concurrent cytotoxicity (Halvey et al. 2007 ), a fact corroborated with our DAAO-ΔPTS mutants showing no elevated cytotoxicity in the presence of d-amino acids (data not shown). Since only mild cell shedding and mild regenerative proliferation was observed in vivo yet without concomitantly increased renal proximal tumor incidences (Dietrich et al. 2008) , it would appear unlikely that mislocalized peroxisomal DAAO in renal proximal cells results in overt cytotoxicity or sublethal DNA damage with subsequent increased mutation rates.
Of importance is also the recent finding that PEX5, the cytosolic receptor of PTS1 proteins, was identified as a CRM1 cargo, allowing not only the rapid export of mislocalized nuclear PEX5 alone but likely also co-transport of PEX5-PTS1 protein complexes (Kirli et al. 2015) . Still, our data show that inhibition of the nuclear export machinery did not affect DAAO localization, thereby indicating that nuclear export is most likely not involved in the formation of nuclear accumulations in vivo. In contrast, inhibition of the peroxisomal import did result in more intense nuclear DAAO localization in our cell systems. Therefore, we suggest that any influence on the peroxisomal import machinery or peroxins by pharmaceuticals (propiverine, NSRI) could lead to a local protein overload that exceeds the Box-and-whisk- ers plot shows median and 10-90 percentile, ns = not significant, *p < 0.0001. DAAO = EYFP-tagged human/rat DAAO. PTS = peroxisomal targeting signal. NES = nuclear export signal. Scale bar 10 µm degradation capacity within the nucleus. Therefore, cells start to compartmentalize the protein as a common stress response (Tyedmers et al. 2010 ) resulting in dense accumulations as observed in vivo subsequent to pharmaceutical treatment or after inhibition of the proteasomal degradation in vitro. Upon cessation of drug exposure, i.e., when the system has regained sufficient capacity to deal with the protein overload (Latonen 2011) , the nucleus will be cleared from accumulations. Indeed, drug-induced DAAO accumulations were proven to be reversible (Nakano et al. 1989; Yamashita et al. 1990 ). In conclusion, we suggest that drug-induced protein accumulations in rat proximal tubule cells in vivo arise from a reversible interference with the peroxisomal import machinery.
